AML WITH GENE MUTATIONS
Clinical trials for AML WITH GENE MUTATIONS explained in plain language.
Never miss a new study
Get alerted when new AML WITH GENE MUTATIONS trials appear
Sign up with your email to follow new studies for AML WITH GENE MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail targets tough leukemia mutations
Disease control Recruiting nowThis early-phase trial tests a new drug called revumenib alongside standard chemotherapy and another targeted drug (midostaurin) for adults newly diagnosed with acute myeloid leukemia (AML) that has specific genetic changes (NPM1 and FLT3 mutations). The study aims to find a safe…
Matched conditions: AML WITH GENE MUTATIONS
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for Hard-to-Treat leukemia? early trial launches
Disease control Recruiting nowThis early-stage trial tests a new oral drug, ZE46-0134, in 150 adults whose acute myeloid leukemia (AML) has come back or not responded to standard treatment. The study focuses on people with specific gene changes (FLT3 or spliceosome mutations). The main goals are to check safe…
Matched conditions: AML WITH GENE MUTATIONS
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC